Cellulose acylation in homogeneous and heterogeneous media: Optimization of reactions conditions.

The dependence of the DS on the acid anhydride/anhydroglucose unit ((RCO)2O/AGU) molar ratio was correlated using second-order polynomials. The regression coefficients of the (RCO)2O/AGU terms showed that increasing the length of the RCO group of the anhydride led to lower values of DS. For acylation under heterogeneous reaction conditions, the following were employed: acid anhydrides and butyryl chloride as acylating agents; iodine as a catalyst; N,N-dimethylformamide (DMF) as a solvent, pyridine, and triethylamine as solvents and catalysts. For acylation using acetic anhydride plus iodine, the values of DS correlate with reaction time by a second-order polynomial. Due to its role as a polar solvent and a nucleophilic catalyst, pyridine was the most effective base catalyst, independent of the acylating agent (butyric anhydride and butyryl chloride).

Cell Viability of Porous Poly(d,l-lactic acid)/Vertically Aligned Carbon Nanotubes/Nanohydroxyapatite Scaffolds for Osteochondral Tissue Engineering.

Treatment of articular cartilage lesions remains an important challenge. Frequently the bone located below the cartilage is also damaged, resulting in defects known as osteochondral lesions. Tissue engineering has emerged as a potential approach to treat cartilage and osteochondral defects. The principal challenge of osteochondral tissue engineering is to create a scaffold with potential to regenerate both cartilage and the subchondral bone involved, considering the intrinsic properties of each tissue. Recent nanocomposites based on the incorporation of nanoscale fillers into polymer matrix have shown promising results for the treatment of osteochondral defects. In this present study, it was performed using the recently developed methodologies (electrodeposition and immersion in simulated body fluid) to obtain porous superhydrophilic poly(d,l-lactic acid)/vertically aligned carbon nanotubes/nanohydroxyapatite (PDLLA/VACNT-O:nHAp) nanocomposite scaffolds, to analyze cell behavior and gene expression of chondrocytes, and then assess the applicability of this nanobiomaterial for osteochondral regenerative medicine. The results demonstrate that PDLLA/VACNT-O:nHAp nanocomposite supports chondrocytes adhesion and decreases type I Collagen mRNA expression. Therefore, these findings suggest the possibility of novel nanobiomaterial as a scaffold for osteochondral tissue engineering applications.